PTC Therapeutics Inc. buy Wells Fargo & Company
Start price
26.11.24
/
50%
€45.40
Target price
26.11.25
€64.72
Performance (%)
-14.10%
Price
07:36
?
Summary
This prediction is currently active. The prediction for PTC Therapeutics Inc. disappoints with a performance of -14.10%. This prediction currently runs until 26.11.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | -4.505% | -4.505% |
| iShares Core DAX® | 3.109% | -1.011% |
| iShares Nasdaq 100 | 3.088% | 3.918% |
| iShares Nikkei 225® | 4.760% | 5.119% |
| iShares S&P 500 | 1.840% | 2.235% |
Comments by Wells_Fargo___Compan for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Wells Fargo & Company from $56.00 to $68.00. They now have an "overweight" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€39.00
08.08.25
08.08.25
€67.74
08.08.26
08.08.26
0.00%
07:36
07:36
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€43.60
29.07.25
29.07.25
€67.26
29.07.26
29.07.26
-10.55%
07:36
07:36
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.80
27.05.25
27.05.25
€64.95
27.05.26
27.05.26
1.91%
07:36
07:36
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.20
08.12.23
08.12.23
€34.41
08.12.24
08.12.24
78.51%
09.12.24
09.12.24